DiaSorin S.p.A.
DIA
Hisse Senetlerindeki Sıralama
#3764
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Hisse Fiyatı
$89.19
Piyasa Değeri
$4.41B
Değişim (1 gün)
1.61%
Değişim (1 yıl)
-1.46%
Ülke
IT
Ticaret DiaSorin S.p.A. (DIA)
Kategori
Healthcare
DiaSorin S.p.A. (DIA) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $90.91 - 2026-10-01
Gün sonu en düşük fiyat: $16.82 - 2007-07-01
Gün sonu en düşük fiyat: $16.82 - 2007-07-01
DiaSorin S.p.A. için hisse fiyatı geçmişi: 2007 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | 9.76% |
| 2025 | -30.70% |
| 2024 | 7.93% |
| 2023 | -28.26% |
| 2022 | -28.69% |
| 2021 | -5.96% |
| 2020 | 55.52% |
| 2019 | 60.48% |
| 2018 | -9.14% |
| 2017 | 60.80% |
| 2016 | 6.78% |
| 2015 | 29.22% |
| 2014 | -10.91% |
| 2013 | 19.58% |
| 2012 | 46.86% |
| 2011 | -38.72% |
| 2010 | 21.12% |
| 2009 | 94.79% |
| 2008 | -5.47% |
| 2007 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
